AAAAAA
Results:
1-15
|
Results: 15
Authors:
TOLMAN KG
SANDERS SW
BUCHI KN
KAROL MD
JENNINGS DE
RINGHAM GL
Citation: Kg. Tolman et al., THE EFFECTS OF ORAL DOSES OF LANSOPRAZOLE AND OMEPRAZOLE ON GASTRIC PH (VOL 24, PG 65, 1997), Journal of clinical gastroenterology, 26(3), 1998, pp. 232-233
Authors:
GUTNIAK MK
SVARTBERG J
HELLSTROM PM
SANDERS SW
AHREN B
HOLST JJ
ADNER N
Citation: Mk. Gutniak et al., DIFFERENT MODE OF ACTION BY GLP-1 GIVEN BEFORE OR AFTER A MEAL, Diabetologia, 41, 1998, pp. 69-69
Authors:
ARVER S
DOBS AS
MEIKLE AW
CARAMELLI KE
RAJARAM L
SANDERS SW
MAZER NA
Citation: S. Arver et al., LONG-TERM EFFICACY AND SAFETY OF A PERMEATION-ENHANCED TESTOSTERONE TRANSDERMAL SYSTEM IN HYPOGONADAL MEN, Clinical endocrinology, 47(6), 1997, pp. 727-737
Authors:
TOLMAN KG
SANDERS SW
BUCHI KN
KAROL MD
JENNINGS DE
RINGHAM GL
Citation: Kg. Tolman et al., THE EFFECTS OF ORAL DOSES OF LANSOPRAZOLE AND OMEPRAZOLE ON GASTRIC PH, Journal of clinical gastroenterology, 24(2), 1997, pp. 65-70
Authors:
GUTNIAK MK
LARSSON H
SANDERS SW
JUNESKANS O
HOLST JJ
AHREN B
Citation: Mk. Gutniak et al., GLP-1 TABLET IN TYPE-2 DIABETES IN FASTING AND POSTPRANDIAL CONDITIONS, Diabetes care, 20(12), 1997, pp. 1874-1879
Authors:
MEIKLE AW
ARVER S
DOBS AS
ADOLFSSON J
SANDERS SW
MIDDLETON RG
STEPHENSON RA
HOOVER DR
RAJARAM L
MAZER NA
Citation: Aw. Meikle et al., PROSTATE SIZE IN HYPOGONADAL MEN TREATED WITH A NONSCROTAL PERMEATION-ENHANCED TESTOSTERONE TRANSDERMAL SYSTEM, Urology, 49(2), 1997, pp. 191-196
Authors:
SANDERS SW
Citation: Sw. Sanders, TRANSITION FROM TEMPORAL TO BIOLOGICAL-CONTROL IN THE CLINICAL DEVELOPMENT OF CONTROLLED DRUG-DELIVERY SYSTEMS, Journal of controlled release, 39(2-3), 1996, pp. 389-397
Authors:
SANDERS SW
Citation: Sw. Sanders, PATHOGENESIS AND TREATMENT OF ACID PEPTIC DISORDERS - COMPARISON OF PROTON PUMP INHIBITORS WITH OTHER ANTIULCER AGENTS, Clinical therapeutics, 18(1), 1996, pp. 2-34
Authors:
ARVER S
DOBS AS
MEIKLE AW
ALLEN RP
SANDERS SW
MAZER NA
Citation: S. Arver et al., IMPROVEMENT OF SEXUAL FUNCTION IN TESTOSTERONE DEFICIENT MEN TREATED FOR 1 YEAR WITH A PERMEATION ENHANCED TESTOSTERONE TRANSDERMAL SYSTEM, The Journal of urology, 155(5), 1996, pp. 1604-1608
Authors:
MEIKLE AW
ARVER S
DOBS AS
SANDERS SW
RAJARAM L
MAZER NA
Citation: Aw. Meikle et al., PHARMACOKINETICS AND METABOLISM OF A PERMEATION-ENHANCED TESTOSTERONETRANSDERMAL SYSTEM IN HYPOGONADAL MEN - INFLUENCE OF APPLICATION SITE- A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 81(5), 1996, pp. 1832-1840
Authors:
HAN C
JUNG P
SANDERS SW
LIN ET
BENET LZ
Citation: C. Han et al., PHARMACOKINETICS OF NITROGLYCERIN AND ITS 4 METABOLITES DURING NITROGLYCERIN TRANSDERMAL ADMINISTRATION, Biopharmaceutics & drug disposition, 15(2), 1994, pp. 179-183
Authors:
MEIKLE AW
SANDERS SW
TOLMAN KG
JENNINGS DE
KAROL MD
RINGHAM GL
Citation: Aw. Meikle et al., EFFECT OF LANSOPRAZOLE ON MALE HORMONE FUNCTION, Drug investigation, 8(4), 1994, pp. 191-202
Authors:
TOLMAN KG
SANDERS SW
BUCHI KN
Citation: Kg. Tolman et al., GASTRIC PH LEVELS AFTER 15 MG AND 30 MG OF LANSOPRAZOLE AND 20 MG OMEPRAZOLE, Gastroenterology, 106(4), 1994, pp. 10000197-10000197
Authors:
CHEN SA
PERLMAN AJ
SPANSKI N
PETERSON CM
SANDERS SW
JAFFE R
MARTIN M
YALCINKAYA T
CEFALO RC
CHESCHEIR NC
MENARD MK
MORDENTI J
Citation: Sa. Chen et al., THE PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN NONPREGNANT WOMEN AFTER INTRAVENOUS, INTRAVAGINAL, AND INTRACERVICAL ADMINISTRATION, Pharmaceutical research, 10(6), 1993, pp. 834-838
Authors:
MAZER NA
HEIBER WE
MOELLMER JF
MEIKLE AW
STRINGHAM JD
SANDERS SW
TOLMAN KG
ODELL WD
Citation: Na. Mazer et al., ENHANCED TRANSDERMAL DELIVERY OF TESTOSTERONE - A NEW PHYSIOLOGICAL APPROACH FOR ANDROGEN REPLACEMENT IN HYPOGONADAL MEN, Journal of controlled release, 19(1-3), 1992, pp. 347-361
Risultati:
1-15
|